Intrathecal rituximab for the treatment of Epstein-Barr virus-associated encephalitis. [PDF]
Chapuis AG, Orozco JJ, Milano F.
europepmc +1 more source
Beyond the Usual Suspects: Emerging Associations Between Epstein-Barr Virus Infection/Infectious Mononucleosis and Cancers. [PDF]
Muckian MD +4 more
europepmc +1 more source
The case for an Epstein-Barr virus vaccine: Lessons from its link to systemic lupus erythematosus. [PDF]
Akingbola A +6 more
europepmc +1 more source
Experimental Therapies in Multiple Sclerosis: Epstein-Barr Virus and Potential EBV-Related Therapeutic Strategies-A Systematic Review. [PDF]
Bartczak J +6 more
europepmc +1 more source
Mendelian randomization evidence for a causal link between Epstein-Barr virus antibody levels and head and neck cancer risk. [PDF]
Qiu J, Li MF, Guo YM, Yue CF, Pang LJ.
europepmc +1 more source
The pathology of epstein‐barr virus lymphoproliferations
Stefan D. Dojcinov, Matthew R. Pugh
openaire +3 more sources
Epstein-Barr virus and oral health: epidemiology, pathogenesis, clinical aspects, and diagnostic insights: a narrative review. [PDF]
Sriram S +4 more
europepmc +1 more source
Network analysis of Mycoplasma pneumoniae pneumonia and Epstein-Barr virus co-infection. [PDF]
Song J +6 more
europepmc +1 more source
Epstein-Barr virus-associated smooth muscle tumor of the lung in a child: a case report and literature review. [PDF]
Chang X +6 more
europepmc +1 more source
Targeting Epstein-Barr virus is a viable therapeutic strategy in multiple sclerosis: Commentary. [PDF]
Hedström AK.
europepmc +1 more source

